Evelyn Partners’s Microbot Medical MBOT Stock Holding History

Evelyn Partners’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1	Hold	1	–	–	﹤0.01%	669
2026 Q2	$2	Buy	+1	New	+$2	﹤0.01%	550

Other funds holding MBOT

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

DnB Asset Management Oslo, Norway $38B AUM 25.01% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Evelyn Partners's MBOT Position: Q3 2026 in Review

Evelyn Partners held its Microbot Medical (MBOT) position steady in Q3 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #669.

Evelyn Partners first reported a position in MBOT in Q2 2026 and has held it in 2 quarters since. The position peaked at $2 in Q2 2026. 61 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.

Evelyn Partners held 1 share of Microbot Medical worth $1 as of Q3 2026.
Evelyn Partners left its Microbot Medical share count unchanged in Q3 2026.
Microbot Medical made up ﹤0.01% of Evelyn Partners's portfolio in Q3 2026, its #669 holding.
Evelyn Partners first reported a position in Microbot Medical in Q2 2026 and has held it in 2 quarters since.
Evelyn Partners's Microbot Medical position peaked at $2 in Q2 2026.
61 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.

Based on Evelyn Partners's 13F filing for Q3 2026, filed 10 Nov 2026.